Prot #BTCRC-GI13-002: An Open Label Randomized Phase I/II Trial of MLN0128 Compared to Sorafenib in Patients with Advanced or Metastatic Hepatocellular Carcinoma: Big Ten Cancer Research Consortium

Project: Research project

StatusActive
Effective start/end date11/14/1711/14/20

Funding

  • Hoosier Cancer Research Network, Inc. (BTCRC-GI13-002)
  • Millennium Pharmaceuticals, Inc (BTCRC-GI13-002)